Report Detail
Global Gene Delivery or Gene Therapy Drug Market Growth (Status and Outlook) 2022-2028
- RnM4484361 |
- 22 August, 2022 |
- Global |
- 104 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global market for Gene Delivery or Gene Therapy Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Gene Delivery or Gene Therapy Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Gene Delivery or Gene Therapy Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Gene Delivery or Gene Therapy Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Gene Delivery or Gene Therapy Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Gene Delivery or Gene Therapy Drug players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Gene Delivery or Gene Therapy Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Gene Delivery or Gene Therapy Drug market, with both quantitative and qualitative data, to help readers understand how the Gene Delivery or Gene Therapy Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Gene Delivery or Gene Therapy Drug market and forecasts the market size by Type (Viral Gene Delivery System and Non-viral Gene Delivery System,), by Application (Neurological Diseases, Cancer and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Viral Gene Delivery System
Non-viral Gene Delivery System
Segmentation by application
Neurological Diseases
Cancer
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Chapter Introduction
Chapter 1: Scope of Gene Delivery or Gene Therapy Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Gene Delivery or Gene Therapy Drug market size and CAGR, Gene Delivery or Gene Therapy Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Gene Delivery or Gene Therapy Drug revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Gene Delivery or Gene Therapy Drug revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Gene Delivery or Gene Therapy Drug market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Gene Delivery or Gene Therapy Drug Market Size 2017-2028
- 2.1.2 Gene Delivery or Gene Therapy Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Gene Delivery or Gene Therapy Drug Segment by Type
- 2.2.1 Viral Gene Delivery System
- 2.2.2 Non-viral Gene Delivery System
- 2.3 Gene Delivery or Gene Therapy Drug Market Size by Type
- 2.3.1 Gene Delivery or Gene Therapy Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Gene Delivery or Gene Therapy Drug Market Size Market Share by Type (2017-2022)
- 2.4 Gene Delivery or Gene Therapy Drug Segment by Application
- 2.4.1 Neurological Diseases
- 2.4.2 Cancer
- 2.4.3 Other
- 2.5 Gene Delivery or Gene Therapy Drug Market Size by Application
- 2.5.1 Gene Delivery or Gene Therapy Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Gene Delivery or Gene Therapy Drug Market Size Market Share by Application (2017-2022)
3 Gene Delivery or Gene Therapy Drug Market Size by Player
- 3.1 Gene Delivery or Gene Therapy Drug Market Size Market Share by Players
- 3.1.1 Global Gene Delivery or Gene Therapy Drug Revenue by Players (2020-2022)
- 3.1.2 Global Gene Delivery or Gene Therapy Drug Revenue Market Share by Players (2020-2022)
- 3.2 Global Gene Delivery or Gene Therapy Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Gene Delivery or Gene Therapy Drug by Regions
- 4.1 Gene Delivery or Gene Therapy Drug Market Size by Regions (2017-2022)
- 4.2 Americas Gene Delivery or Gene Therapy Drug Market Size Growth (2017-2022)
- 4.3 APAC Gene Delivery or Gene Therapy Drug Market Size Growth (2017-2022)
- 4.4 Europe Gene Delivery or Gene Therapy Drug Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Gene Delivery or Gene Therapy Drug Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Gene Delivery or Gene Therapy Drug Market Size by Country (2017-2022)
- 5.2 Americas Gene Delivery or Gene Therapy Drug Market Size by Type (2017-2022)
- 5.3 Americas Gene Delivery or Gene Therapy Drug Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Gene Delivery or Gene Therapy Drug Market Size by Region (2017-2022)
- 6.2 APAC Gene Delivery or Gene Therapy Drug Market Size by Type (2017-2022)
- 6.3 APAC Gene Delivery or Gene Therapy Drug Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Gene Delivery or Gene Therapy Drug by Country (2017-2022)
- 7.2 Europe Gene Delivery or Gene Therapy Drug Market Size by Type (2017-2022)
- 7.3 Europe Gene Delivery or Gene Therapy Drug Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Gene Delivery or Gene Therapy Drug by Region (2017-2022)
- 8.2 Middle East & Africa Gene Delivery or Gene Therapy Drug Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Gene Delivery or Gene Therapy Drug Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Gene Delivery or Gene Therapy Drug Market Forecast
- 10.1 Global Gene Delivery or Gene Therapy Drug Forecast by Regions (2023-2028)
- 10.1.1 Global Gene Delivery or Gene Therapy Drug Forecast by Regions (2023-2028)
- 10.1.2 Americas Gene Delivery or Gene Therapy Drug Forecast
- 10.1.3 APAC Gene Delivery or Gene Therapy Drug Forecast
- 10.1.4 Europe Gene Delivery or Gene Therapy Drug Forecast
- 10.1.5 Middle East & Africa Gene Delivery or Gene Therapy Drug Forecast
- 10.2 Americas Gene Delivery or Gene Therapy Drug Forecast by Country (2023-2028)
- 10.2.1 United States Gene Delivery or Gene Therapy Drug Market Forecast
- 10.2.2 Canada Gene Delivery or Gene Therapy Drug Market Forecast
- 10.2.3 Mexico Gene Delivery or Gene Therapy Drug Market Forecast
- 10.2.4 Brazil Gene Delivery or Gene Therapy Drug Market Forecast
- 10.3 APAC Gene Delivery or Gene Therapy Drug Forecast by Region (2023-2028)
- 10.3.1 China Gene Delivery or Gene Therapy Drug Market Forecast
- 10.3.2 Japan Gene Delivery or Gene Therapy Drug Market Forecast
- 10.3.3 Korea Gene Delivery or Gene Therapy Drug Market Forecast
- 10.3.4 Southeast Asia Gene Delivery or Gene Therapy Drug Market Forecast
- 10.3.5 India Gene Delivery or Gene Therapy Drug Market Forecast
- 10.3.6 Australia Gene Delivery or Gene Therapy Drug Market Forecast
- 10.4 Europe Gene Delivery or Gene Therapy Drug Forecast by Country (2023-2028)
- 10.4.1 Germany Gene Delivery or Gene Therapy Drug Market Forecast
- 10.4.2 France Gene Delivery or Gene Therapy Drug Market Forecast
- 10.4.3 UK Gene Delivery or Gene Therapy Drug Market Forecast
- 10.4.4 Italy Gene Delivery or Gene Therapy Drug Market Forecast
- 10.4.5 Russia Gene Delivery or Gene Therapy Drug Market Forecast
- 10.5 Middle East & Africa Gene Delivery or Gene Therapy Drug Forecast by Region (2023-2028)
- 10.5.1 Egypt Gene Delivery or Gene Therapy Drug Market Forecast
- 10.5.2 South Africa Gene Delivery or Gene Therapy Drug Market Forecast
- 10.5.3 Israel Gene Delivery or Gene Therapy Drug Market Forecast
- 10.5.4 Turkey Gene Delivery or Gene Therapy Drug Market Forecast
- 10.5.5 GCC Countries Gene Delivery or Gene Therapy Drug Market Forecast
- 10.6 Global Gene Delivery or Gene Therapy Drug Forecast by Type (2023-2028)
- 10.7 Global Gene Delivery or Gene Therapy Drug Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Biogen
- 11.1.1 Biogen Company Information
- 11.1.2 Biogen Gene Delivery or Gene Therapy Drug Product Offered
- 11.1.3 Biogen Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Biogen Main Business Overview
- 11.1.5 Biogen Latest Developments
- 11.2 Novartis
- 11.2.1 Novartis Company Information
- 11.2.2 Novartis Gene Delivery or Gene Therapy Drug Product Offered
- 11.2.3 Novartis Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Novartis Main Business Overview
- 11.2.5 Novartis Latest Developments
- 11.3 Gilead Sciences
- 11.3.1 Gilead Sciences Company Information
- 11.3.2 Gilead Sciences Gene Delivery or Gene Therapy Drug Product Offered
- 11.3.3 Gilead Sciences Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Gilead Sciences Main Business Overview
- 11.3.5 Gilead Sciences Latest Developments
- 11.4 Sarepta Therapeutics
- 11.4.1 Sarepta Therapeutics Company Information
- 11.4.2 Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Product Offered
- 11.4.3 Sarepta Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Sarepta Therapeutics Main Business Overview
- 11.4.5 Sarepta Therapeutics Latest Developments
- 11.5 Alnylam Pharmaceuticals
- 11.5.1 Alnylam Pharmaceuticals Company Information
- 11.5.2 Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Product Offered
- 11.5.3 Alnylam Pharmaceuticals Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Alnylam Pharmaceuticals Main Business Overview
- 11.5.5 Alnylam Pharmaceuticals Latest Developments
- 11.6 Amgen
- 11.6.1 Amgen Company Information
- 11.6.2 Amgen Gene Delivery or Gene Therapy Drug Product Offered
- 11.6.3 Amgen Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Amgen Main Business Overview
- 11.6.5 Amgen Latest Developments
- 11.7 Spark Therapeutics
- 11.7.1 Spark Therapeutics Company Information
- 11.7.2 Spark Therapeutics Gene Delivery or Gene Therapy Drug Product Offered
- 11.7.3 Spark Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Spark Therapeutics Main Business Overview
- 11.7.5 Spark Therapeutics Latest Developments
- 11.8 Akcea Therapeutics
- 11.8.1 Akcea Therapeutics Company Information
- 11.8.2 Akcea Therapeutics Gene Delivery or Gene Therapy Drug Product Offered
- 11.8.3 Akcea Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Akcea Therapeutics Main Business Overview
- 11.8.5 Akcea Therapeutics Latest Developments
- 11.9 Sunway Biotech
- 11.9.1 Sunway Biotech Company Information
- 11.9.2 Sunway Biotech Gene Delivery or Gene Therapy Drug Product Offered
- 11.9.3 Sunway Biotech Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Sunway Biotech Main Business Overview
- 11.9.5 Sunway Biotech Latest Developments
- 11.10 SIBIONO
- 11.10.1 SIBIONO Company Information
- 11.10.2 SIBIONO Gene Delivery or Gene Therapy Drug Product Offered
- 11.10.3 SIBIONO Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 SIBIONO Main Business Overview
- 11.10.5 SIBIONO Latest Developments
- 11.11 AnGes
- 11.11.1 AnGes Company Information
- 11.11.2 AnGes Gene Delivery or Gene Therapy Drug Product Offered
- 11.11.3 AnGes Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 AnGes Main Business Overview
- 11.11.5 AnGes Latest Developments
- 11.12 Orchard Therapeutics
- 11.12.1 Orchard Therapeutics Company Information
- 11.12.2 Orchard Therapeutics Gene Delivery or Gene Therapy Drug Product Offered
- 11.12.3 Orchard Therapeutics Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Orchard Therapeutics Main Business Overview
- 11.12.5 Orchard Therapeutics Latest Developments
- 11.13 Human Stem Cells Institute
- 11.13.1 Human Stem Cells Institute Company Information
- 11.13.2 Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Product Offered
- 11.13.3 Human Stem Cells Institute Gene Delivery or Gene Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Human Stem Cells Institute Main Business Overview
- 11.13.5 Human Stem Cells Institute Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Gene Delivery or Gene Therapy Drug. Industry analysis & Market Report on Gene Delivery or Gene Therapy Drug is a syndicated market report, published as Global Gene Delivery or Gene Therapy Drug Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Gene Delivery or Gene Therapy Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
